tirzepatide and semaglutide therapeutic modality Ozempic® (semaglutide) Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Adults with obesity who discontinue

They are provided to help interpret the literature, not as a protocol for human use

Over a longer period, such as 72 weeks, clinical studies show average weight reductions of 15% to 21% of total body weight, especially when paired with healthy eating and physical activity

Surgical intervention rates remained comparable between Tirzepatide and Semaglutide (HR 1.92, 95% CI 0.635.87, p = 0.25)

It is commonly used to help manage blood sugar levels in adults with type 2 diabetes

Activate here: zepbound.lilly.com/savings See complete savings card guide Save Your Card Details After activating, save your BIN, PCN, and Group number (pharmacy processing codes)

I will begin Month 2 after next week